Saratoga Analysis & Funding Administration raised its stake in shares of Johnson & Johnson (NYSE:JNJ – Get Score) by 9.3% within the third quarter, based on its most up-to-date submitting with the Securities & Alternate Fee. The institutional investor owned 416,439 shares of the corporate’s inventory after shopping for a further 35,409 shares through the quarter. Johnson & Johnson contains 3.6% of Saratoga Analysis & Funding Administration’s portfolio, making the inventory its thirteenth largest holding. Saratoga Analysis & Funding Administration’s holdings in Johnson & Johnson had been value $68,029,000 as of its most up-to-date submitting with the Securities & Alternate Fee.
Quite a few different hedge funds additionally just lately purchased and bought shares of the corporate. Worth T Rowe Associates Inc. MD lifted its stake in shares of Johnson & Johnson by 18.9% through the 2nd quarter. Worth T Rowe Associates Inc. MD now owns 24,622,795 shares of the corporate’s inventory value $4,370,793,000 after buying a further 3,912,430 shares over the past quarter. FMR LLC lifted its stake in shares of Johnson & Johnson by 20.8% through the 2nd quarter. FMR LLC now owns 18,725,049 shares of the corporate’s inventory value $3,323,883,000 after buying a further 3,229,032 shares over the past quarter. GQG Companions LLC lifted its stake in shares of Johnson & Johnson by 64.4% through the 1st quarter. GQG Companions LLC now owns 6,501,761 shares of the corporate’s inventory value $1,151,931,000 after buying a further 2,547,378 shares over the past quarter. DZ BANK AG Deutsche Zentral Genossenschafts Financial institution Frankfurt am Primary lifted its stake in shares of Johnson & Johnson by 52.2% through the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Financial institution Frankfurt am Primary now owns 6,102,999 shares of the corporate’s inventory value $1,083,329,000 after buying a further 2,093,392 shares over the past quarter. Lastly, Arrowstreet Capital Restricted Partnership elevated its holdings in Johnson & Johnson by 37.2% through the 1st quarter. Arrowstreet Capital Restricted Partnership now owns 6,653,610 shares of the corporate’s inventory value $1,179,219,000 after buying a further 1,805,632 shares through the interval. Institutional buyers personal 67.94% of the corporate’s inventory.
Insider Transactions at Johnson & Johnson
In different information, insider William Hait bought 15,000 shares of the enterprise’s inventory in a transaction that occurred on Monday, October twenty fourth. The inventory was bought at a mean worth of $171.55, for a complete transaction of $2,573,250.00. Following the sale, the insider now owns 80,236 shares of the corporate’s inventory, valued at roughly $13,764,485.80. The sale was disclosed in a submitting with the Securities & Alternate Fee, which is on the market by way of this hyperlink. In associated information, CFO Joseph J. Wolk bought 14,781 shares of the agency’s inventory in a transaction that occurred on Tuesday, December thirteenth. The shares had been bought at a mean worth of $179.60, for a complete transaction of $2,654,667.60. Following the completion of the sale, the chief monetary officer now instantly owns 35,812 shares within the firm, valued at $6,431,835.20. The sale was disclosed in a authorized submitting with the Securities & Alternate Fee, which is on the market at this hyperlink. Additionally, insider William Hait bought 15,000 shares of the agency’s inventory in a transaction that occurred on Monday, October twenty fourth. The inventory was bought at a mean worth of $171.55, for a complete transaction of $2,573,250.00. Following the sale, the insider now owns 80,236 shares of the corporate’s inventory, valued at $13,764,485.80. The disclosure for this sale might be discovered right here. Insiders have bought 277,886 shares of firm inventory value $48,550,549 over the past quarter. 0.35% of the inventory is at present owned by insiders.
Johnson & Johnson Worth Efficiency
Shares of NYSE:JNJ opened at $168.74 on Friday. Johnson & Johnson has a 1-year low of $155.72 and a 1-year excessive of $186.69. The corporate has a debt-to-equity ratio of 0.37, a present ratio of 1.43 and a fast ratio of 1.18. The enterprise has a fifty day transferring common worth of $176.14 and a 200-day transferring common worth of $171.30. The corporate has a market capitalization of $441.17 billion, a PE ratio of 23.50, a PEG ratio of three.28 and a beta of 0.56.
Johnson & Johnson (NYSE:JNJ – Get Score) final issued its earnings outcomes on Tuesday, October 18th. The corporate reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.49 by $0.06. Johnson & Johnson had a return on fairness of 35.37% and a internet margin of 19.95%. The enterprise had income of $23.79 billion through the quarter, in comparison with analysts’ expectations of $23.44 billion. Throughout the identical interval within the prior yr, the enterprise earned $2.60 EPS. The enterprise’s income for the quarter was up 1.9% in comparison with the identical quarter final yr. As a gaggle, equities analysts anticipate that Johnson & Johnson will submit 10.04 EPS for the present fiscal yr.
Johnson & Johnson Dividend Announcement
The enterprise additionally just lately introduced a quarterly dividend, which shall be paid on Tuesday, March seventh. Stockholders of report on Tuesday, February twenty first shall be paid a $1.13 dividend. The ex-dividend date is Friday, February seventeenth. This represents a $4.52 dividend on an annualized foundation and a dividend yield of two.68%. Johnson & Johnson’s payout ratio is 62.95%.
Analysts Set New Worth Targets
JNJ has been the subject of a lot of analyst reviews. Raymond James reduce their worth goal on Johnson & Johnson from $192.00 to $185.00 and set an “outperform” score on the inventory in a report on Wednesday, October nineteenth. Credit score Suisse Group started protection on shares of Johnson & Johnson in a analysis report on Thursday, November seventeenth. They set a “impartial” score and a $170.00 worth goal for the corporate. Sanford C. Bernstein dropped their worth goal on shares of Johnson & Johnson from $194.00 to $190.00 in a analysis be aware on Wednesday, October nineteenth. Atlantic Securities lowered their worth goal on shares of Johnson & Johnson from $165.00 to $160.00 and set a “impartial” score for the corporate in a analysis be aware on Wednesday, October nineteenth. Lastly, StockNews.com assumed protection on shares of Johnson & Johnson in a analysis be aware on Wednesday, October twelfth. They set a “strong-buy” score for the corporate. Seven funding analysts have rated the inventory with a maintain score, 5 have assigned a purchase score and one has given a powerful purchase score to the inventory. In keeping with MarketBeat.com, the corporate has a mean score of “Reasonable Purchase” and a consensus worth goal of $181.75.
About Johnson & Johnson
(Get Score)
Johnson & Johnson is a holding firm, which engages within the analysis and growth, manufacture and sale of merchandise within the well being care discipline. It operates by way of the next segments: Client Well being, Pharmaceutical, and Medical Gadgets. The Client Well being section contains merchandise used within the child care, oral care, magnificence, over-the-counter pharmaceutical, girls’s well being, and wound care markets.
Featured Tales
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Get Score).
Obtain Information & Rankings for Johnson & Johnson Every day – Enter your e-mail tackle under to obtain a concise day by day abstract of the most recent information and analysts’ scores for Johnson & Johnson and associated firms with MarketBeat.com’s FREE day by day e-mail publication.
